Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sero-prevalence of Hepatitis A Varicella-Zoster Virus, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis in Mexico

NCT01160081 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01160081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01160081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sero-prevalence of Hepatitis A Varicella-Zoster Virus, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis in Mexico
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
March 31, 2010
Completion date
September 30, 2010
Enrollment
3,658 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bordetella pertussis infection, cytomegalovirus, hepatitis a, herpes simplex (1 and 2), varicella-zoster virus, viral hepatitis vaccines